Suppr超能文献

心力衰竭患者中与金属蛋白酶9(MMP-9)和金属蛋白酶组织抑制剂1(TIMP-1)基因转录活性相关的危险因素

Risk Factors Association with Transcriptional Activity of Metalloproteinase 9 (MMP-9) and Tissue Inhibitor of Metalloproteinases 1 (TIMP-1) Genes in Patients with Heart Failure.

作者信息

Dąbek Józefa, Korzeń Dariusz, Sierka Oskar, Paluszkiewicz Lech, Milting Hendrik, Gąsior Zbigniew

机构信息

Department of Cardiology, Faculty of Health Sciences in Katowice, Medical University of Silesia in Katowice, Ziołowa Street 45/47, 40-635 Katowice, Poland.

Voivodeship Specialist Hospital Megrez Sp. z o. o., Edukacji Street 102, 43-100 Tychy, Poland.

出版信息

Biomedicines. 2024 Mar 7;12(3):601. doi: 10.3390/biomedicines12030601.

Abstract

The aim of the study was to assess the occurrence of classic risk factors in the study group of patients with heart failure and to link them with the transcriptional activity of the examined genes: and the . A total of 150 (100%) patients qualified for the study, including 80 (53.33%) patients with heart failure in the course of coronary artery disease, 40 (26.67%) with coronary artery disease without heart failure, and 30 (20.00%) in whom the presence of atherosclerotic changes in the coronary arteries was excluded. The material for molecular tests was peripheral blood collected from patients within the first 24 h of hospitalisation. A quantitative analysis of transcriptional activity was performed using the RT-qPCR technique. The most common classic risk factors among the patients in the study group were arterial hypertension (117; 78.00%) and overweight/obesity (102; 68%). In the group of patients with coronary artery disease and heart failure burdened with overweight/obesity, a significantly higher transcriptional activity of the gene was found in comparison to patients who were not burdened with this risk factor. The analysis also showed the statistically significant higher transcriptional activity of the gene in a group of patients with coronary artery disease and heart failure who smoked. The examined patients with heart failure due to myocardial ischemia were burdened with numerous cardiovascular risk factors, the most common of which were arterial hypertension, obesity/overweight, and hypercholesterolemia. A significant increase in the transcriptional activity of the gene in the presence of risk factors (male sex, overweight/obesity, smoking) indicates another pathomechanism of their action and participation in the development and progression of heart failure during myocardial ischemia. There is a need for systematic information and educational activities promoting a healthy lifestyle with the elimination of modifiable risk factors for cardiovascular diseases.

摘要

本研究的目的是评估心力衰竭患者研究组中经典危险因素的发生率,并将其与所检测基因: 和 的转录活性联系起来。共有150名(100%)患者符合研究条件,其中80名(53.33%)患有冠状动脉疾病并发心力衰竭,40名(26.67%)患有冠状动脉疾病但无心力衰竭,30名(20.00%)排除了冠状动脉粥样硬化改变。分子检测的材料是患者入院后24小时内采集的外周血。使用RT-qPCR技术进行转录活性的定量分析。研究组患者中最常见的经典危险因素是动脉高血压(117例;78.00%)和超重/肥胖(102例;68%)。在患有冠状动脉疾病并发心力衰竭且超重/肥胖的患者组中,与未受此危险因素影响的患者相比,发现 基因的转录活性显著更高。分析还显示,在患有冠状动脉疾病并发心力衰竭且吸烟的患者组中, 基因的转录活性在统计学上显著更高。因心肌缺血导致心力衰竭的受试患者存在多种心血管危险因素,其中最常见的是动脉高血压、肥胖/超重和高胆固醇血症。在存在危险因素(男性、超重/肥胖、吸烟)的情况下, 基因转录活性的显著增加表明了它们作用的另一种病理机制,并参与了心肌缺血期间心力衰竭的发生和发展。有必要开展系统的宣传和教育活动,倡导健康的生活方式,消除心血管疾病的可改变危险因素。

相似文献

10
[Mechanism of tanshinone II A inhibiting myocardial remodeling by Galectin-3].丹参酮IIA通过半乳糖凝集素-3抑制心肌重构的机制
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 Jun;34(6):640-645. doi: 10.3760/cma.j.cn121430-20220309-00232.

本文引用的文献

6
Blood pressure and heart failure.血压与心力衰竭
Clin Hypertens. 2020 Jan 2;26:1. doi: 10.1186/s40885-019-0132-x. eCollection 2020.
10
Primary Prevention of Cardiovascular Disease in Diabetes Mellitus.糖尿病患者心血管疾病的一级预防
J Am Coll Cardiol. 2017 Aug 15;70(7):883-893. doi: 10.1016/j.jacc.2017.07.001.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验